Drug Type Small molecule drug |
Synonyms Compound 1(AItenea Biotech) |
Target |
Action inhibitors |
Mechanism DYRK1A inhibitors(Dual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Spain | 03 May 2025 | |
Neurodegenerative Diseases | Preclinical | Spain | 03 May 2025 |